166 related articles for article (PubMed ID: 14981949)
1. Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Yamanaka H
Anticancer Res; 2003; 23(6D):4941-6. PubMed ID: 14981949
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
3. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women.
Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF
Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421
[TBL] [Abstract][Full Text] [Related]
4. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
[TBL] [Abstract][Full Text] [Related]
5. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
[TBL] [Abstract][Full Text] [Related]
6. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
[TBL] [Abstract][Full Text] [Related]
7. A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides.
Dialyna I; Tzanakakis G; Dolapsakis G; Tsatsakis A
Toxicol Lett; 2004 Jun; 151(1):267-71. PubMed ID: 15177662
[TBL] [Abstract][Full Text] [Related]
8. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.
Dick IM; Devine A; Prince RL
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
10. No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer.
Li L; Cicek MS; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2280-1. PubMed ID: 15598794
[No Abstract] [Full Text] [Related]
11. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
[TBL] [Abstract][Full Text] [Related]
12. A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer.
Young IE; Kurian KM; MacKenzie MA; Kunkler IH; Cohen BB; Hooper ML; Wyllie AH; Steel CM
Br J Cancer; 2000 Apr; 82(7):1247-8. PubMed ID: 10755395
[TBL] [Abstract][Full Text] [Related]
13. Linkage between prostate cancer incidence and different alleles of the human Y-linked tetranucleotide polymorphism DYS19.
Ewis AA; Lee J; Naroda T; Sasahara K; Sano T; Kagawa S; Iwamoto T; Nakahori Y
J Med Invest; 2002 Feb; 49(1-2):56-60. PubMed ID: 11901761
[TBL] [Abstract][Full Text] [Related]
14. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
Tsuchiya N; Wang L; Suzuki H; Segawa T; Fukuda H; Narita S; Shimbo M; Kamoto T; Mitsumori K; Ichikawa T; Ogawa O; Nakamura A; Habuchi T
J Clin Oncol; 2006 May; 24(13):1982-9. PubMed ID: 16648498
[TBL] [Abstract][Full Text] [Related]
15. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
[TBL] [Abstract][Full Text] [Related]
18. Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease.
Hamano T; Matsui H; Sekine Y; Ohtake N; Nakata S; Suzuki K
J Urol; 2010 Aug; 184(2):738-42. PubMed ID: 20639049
[TBL] [Abstract][Full Text] [Related]
19. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women.
Baghaei F; Rosmond R; Westberg L; Hellstrand M; Eriksson E; Holm G; Björntorp P
Obes Res; 2003 Apr; 11(4):578-85. PubMed ID: 12690088
[TBL] [Abstract][Full Text] [Related]
20. Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
Suzuki K; Ohtake N; Nakata S; Takei T; Matsui H; Ono Y; Nakazato H; Hasumi M; Koike H; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
Anticancer Res; 2002; 22(6B):3507-11. PubMed ID: 12552947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
